Burcon Nutrascience Corporation BU.TO
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 2.31M | 1.64M | 1.07M | 580.30K | 350.70K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.31M | 1.64M | 1.07M | 580.30K | 350.70K |
| Cost of Revenue | 8.20M | 7.10M | 4.97M | 3.51M | 2.10M |
| Gross Profit | -5.89M | -5.47M | -3.91M | -2.93M | -1.75M |
| SG&A Expenses | 2.22M | 2.16M | 2.23M | 2.37M | 2.49M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 11.04M | 9.88M | 8.23M | 7.11M | 6.39M |
| Operating Income | -8.72M | -8.24M | -7.16M | -6.53M | -6.04M |
| Income Before Tax | -10.96M | -10.59M | -9.26M | -7.97M | -7.09M |
| Income Tax Expenses | -433.90K | -284.20K | -- | -- | -- |
| Earnings from Continuing Operations | -10.53 | -10.31 | -9.26 | -7.97 | -7.09 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -10.53M | -10.31M | -9.26M | -7.97M | -7.09M |
| EBIT | -8.72M | -8.24M | -7.16M | -6.53M | -6.04M |
| EBITDA | -6.32M | -7.81M | -6.75M | -6.11M | -5.60M |
| EPS Basic | -0.83 | -0.81 | -0.76 | -0.74 | -0.78 |
| Normalized Basic EPS | -0.54 | -0.52 | -0.48 | -0.46 | -0.49 |
| EPS Diluted | -0.83 | -0.81 | -0.77 | -0.74 | -0.78 |
| Normalized Diluted EPS | -0.54 | -0.52 | -0.48 | -0.46 | -0.49 |
| Average Basic Shares Outstanding | 50.76M | 50.76M | 48.00M | 42.44M | 36.86M |
| Average Diluted Shares Outstanding | 50.76M | 50.76M | 48.00M | 42.44M | 36.86M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |